Reveal-Dx

📍 Seattle, United States🗓 Founded 2014👥 12 employees💰 Last funded May 2023
Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI enabled, lung cancer decision support software to the mainstream market, driving the optimal clinical pathway for each patient. Reveal-Dx is a young company, started in early 2021, but we jump started the company by purchasing the assets of Mindshare Medical in March. Mindshare had invested millions of dollars and over 5 years of research developing core, patented algorithms that were actively being deployed in the clinic for validation.
5
Total investors
0
Early stage
3
Mid stage
2
Late stage
2014
Founded
Investor geography2 countries
United States
4
Canada
1
Investor activity2017–2023 · investors recorded per year
20172201812022120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Reveal-Dx?
Reveal-Dx has 5 investors on record on gritt.io, 3 mid-stage and 2 late-stage investors.
When did Reveal-Dx last raise funding?
The most recent investment in Reveal-Dx recorded on gritt.io was in May 2023.
When was Reveal-Dx founded?
Reveal-Dx was founded in 2014.
What industry is Reveal-Dx in?
Reveal-Dx operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Reveal-Dx based?
Reveal-Dx is headquartered in Seattle, United States.